Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine in Children With Autism
NCT00057408Phase 2Completed
- Sponsor
- Food and Drug Administration
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in Autism Spectrum Disorder (ASD), sponsored by Food and Drug Administration. Started May 2003; status: completed.
02
Drugs
olanzapine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00057408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057408.